There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...
A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...
The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
"For too long, the Parkinson's community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as ...
Advances in Surgical Treatments for Parkinson’s Disease with George Mandybur, M.D., Lee Health neurosurgeon and deep brain stimulation expert. This event will also offer the opportunity to visit ...
A team of researchers has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease. The team, led by ...
MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ability and quality of life in a small midphase trial. A total of 14 ...
Can a common parasite help treat Alzheimer’s? Scientists say Toxoplasma gondii may open pathways to brain therapies for ...
Alzheimer’s disease and Parkinson’s disease are both neurodegenerative diseases. They’re similar in terms of symptoms, treatment, risk factors, and outlook. But there are also differences.